[Federal Register Volume 68, Number 95 (Friday, May 16, 2003)]
[Notices]
[Page 26648]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-12219]



[[Page 26648]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Inter Company Collaboration for Aids Drug 
Development

    Notice is hereby given that, on April 4, 2003, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Inter Company Collaboration for 
AIDS Drug Development (``the Collaboration'') has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing changes in its membership status. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, although there are 
no other changes in the membership, Collaboration member Gilead 
Sciences, Inc. of Foster City, CA, has acquired Collaboration member 
Triangle Pharmaceuticals, Inc. of Durham, NC by merging Triangle with a 
wholly-owned subsidiary of Gilead.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Inter Company Collaboration for AIDS 
Drug Development intends to file additional written notification 
disclosing all changes in membership.
    On May 27, 1993, Inter Company Collaboration for AIDS Drug 
Development filed its original notification pursuant to section 6(a) of 
the Act. The Department of Justice published a notice in the Federal 
Register pursuant to section 6(b) of the Act on July 6, 1993 (58 FR 
36223).
    The last notification was filed with the Department on November 8, 
2001. A notice was published in the Federal Register pursuant to 
section 6(b) of the Act of February 15, 2002 (67 FR 7201).

Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 03-12219 Filed 5-15-03; 8:45 am]
BILLING CODE 4410-11-M